You can protect your vision from the effects of diabetes by controlling your blood sugar intensely blood, according to a recent study.
Were found to have reduced the risk of diabetic retinopathy amid a follow-up analysis made four – People with type 2 diabetes – who intensely controlled your blood sugar in the blood during the milestone action to Control Cardiovascular Risk in Diabetes ( ACCORD) Eye Study Trial years after stopping intensive therapy.
The lead author Emily Chew said this study sends a powerful message to people with type 2 diabetes who are concerned about vision loss diabetes and added that well-controlled blood glucose or sugar level in blood, has a positive effect, measurable and lasting health of the eyes.
Strict glycemic control successfully reduces to an average of 6.4 percent A1C – a measure of average blood glucose – compared with 7.7 percent among participants on standard therapy for glycemic control . Although it failed to reduce the risk of cardiovascular disease – such as heart attack and stroke – the researchers found that the therapy had cut the progression of retinopathy by about one third at the end of ACCORD. The results also suggest a potential role for the continued use of fenofibrate for the treatment of diabetic retinopathy, if taken regularly.
Based on the findings of the ACCORD, fenofibrate might be worth taking to control the progression of diabetic retinopathy. Other countries – including Australia – fenofibrate have approved for the treatment of diabetic retinopathy, but not the US, Chew said.